Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
Hirotoshi Watanabe(Kyoto University), Takeshi Kimura(Kyoto University), Yoshihiro Morino(Iwate Medical University), Yuki Obayashi(Kyoto University), Ryusuke Nishikawa(Obayashi (Japan)), Masaharu Akao(Kyoto Medical Center), Takafumi Yokomatsu(Mitsubishi Kyoto Hospital), Masayuki Doi(Kagawa Prefectural Central Hospital), Kiyoshi Hibi(Yokohama City University Medical Center), Teruo Noguchi(National Cerebral and Cardiovascular Center), Hideki Okayama(Ehime Prefectural Central Hospital), Itsuro Morishima(Ogaki Municipal Hospital), Itaru Takamisawa(Sakakibara Hospital), Kenji Andò(Kokura Memorial Hospital), Ko Yamamoto(Kyoto University), Toshiyuki Noda(Gifu Prefectural General Medical Center), Satoru Suwa(Juntendo University Shizuoka Hospital), Kazushige Kadota(Kurashiki Central Hospital), Takeshi Morimoto(Hyogo Medical University), Ruka Yoshida(Japanese Red Cross Nagoya Daini Hospital), Masahiro Natsuaki(Saga University), Yuichi Nakamura(Star General Hospital), Masahiro Yagi(Sendai Medical Center), Yoshiki Hata, Nobuhiro Suematsu(Saiseikai Fukuoka General Hospital), Hiroki Sakamoto(Kobe University), Koh Ono(Kyoto University)
Cited by 62
Related Papers
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|345